Wedbush Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN), Adds to Best Idea List
Tweet Send to a Friend
Wedbush analyst Liana Moussatos reiterated an Outperform rating and $164.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
